Pages that link to "Q33230253"

The following pages link to Endocannabinoids and drug dependence (Q33230253):

Displaying 25 items.

• Glutamatergic substrates of drug addiction and alcoholism (Q24648924) (← links)
• Differential treatment regimen-related effects of cannabinoids on D1 and D2 receptors in adolescent and adult rat brain (Q28578568) (← links)
• Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol (Q34254854) (← links)
• Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network (Q34613783) (← links)
• Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum (Q34660703) (← links)
• Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry (Q35069558) (← links)
• Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice (Q36057601) (← links)
• Cannabinoid-1 receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting N-acylphosphatidylethanolamine-hydrolyzing phospholipase D terminals. (Q36395211) (← links)
• Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? (Q36900876) (← links)
• Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. (Q37001332) (← links)
• Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex. (Q37003653) (← links)
• Role of endocannabinoids in regulating drug dependence (Q37129779) (← links)
• The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. (Q37142233) (← links)
• Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure (Q37164815) (← links)
• Candidate genes for cannabis use disorders: findings, challenges and directions (Q37245382) (← links)
• ∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells. (Q39538303) (← links)
• HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat. (Q46147054) (← links)
• Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity (Q46323561) (← links)
• Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain (Q46425083) (← links)
• Effects of cocaine in 5-lipoxygenase-deficient mice (Q46713165) (← links)
• Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. (Q46825379) (← links)
• Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels (Q46899274) (← links)
• Effects of endocannabinoid neurotransmission modulators on brain stimulation reward (Q48428879) (← links)
• Two brain sites for cannabinoid reward. (Q48556363) (← links)
• Endocannabinoids in chronic migraine: CSF findings suggest a system failure (Q79374957) (← links)